利妥昔单抗时代联合治疗有限期眼部附属器 DLBCL 患者的长期预后.
关键词: diffuse large B cell lymphoma ocular adnexa orbit outcomes radiation rituximab treatment
Mesh : Humans Rituximab / therapeutic use Combined Modality Therapy Antibodies, Monoclonal, Murine-Derived / therapeutic use Lymphoma, Large B-Cell, Diffuse / drug therapy Antineoplastic Combined Chemotherapy Protocols / therapeutic use
来 源: DOI:10.1111/bjh.18590 PDF(Pubmed)